Clinical trials: in Jordan
Head and Neck (HNSCC)
HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)
This is an international multi-centre, non-inferiority phase III randomized controlled trial comparing concurrent chemoradiation with high dose cisplatin (Arm A) vs.
- Trial name
- NCT07801235
- Testing
- 70 gy 35 fractions/7weeks+high dose of cisplatin, 81.6 Gy /68 fractions BID FOR 7 WEEKS
- Where
- Jordan
- Volunteers
- 604 people
- Sponsor
- King Hussein Cancer Center
Back Pain
Effect of Shock Wave Therapy With Core Stability Exercises for Treatment of Chronic Non-Specific Back Pain
To investigate the Effect of Combined Extracorporeal Shock Wave with core stability Exercise for the Treatment of Chronic Non-Specific Back Pain in Jordanian University Students
- Trial name
- ESW (NCT07319988)
- Testing
- Extracorporeal Shock wave therapy, Therapeutic ultrasound, core stabilization exercise
- Where
- 2 sites in Egypt, Jordan
- Volunteers
- 60 people
- Sponsor
- New Ismailia National University
Chronic Pelvic Pain Syndrome
Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of…
- Trial name
- PEMF (NCT07867808)
- Testing
- pulsed electromagnetic field, hydrotherapy, traditional physical therapy program
- Where
- Jordan
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Horus University
Anterior Knee Pain, Photobiomodulation (PBM)
Photobiomodultion in Anterior Knee Pain
The goal of this clinical trial is to assess the augmented recovery in the adolescent females with patellar tendinopathy using Phot- Biomodulation
- Conditions
- Anterior Knee Pain, Photobiomodulation (PBM), Laser Therapy
- Trial name
- PBM (NCT07865325)
- Testing
- Photobiomodultion with Laser scanning, patellar mobilization with exercise therapy
- Where
- Jordan
- Volunteers
- 104 people, healthy volunteers welcome
- Sponsor
- New Ismailia National University
Adolescent Pregnancy
Effectiveness of a Digital Health Coaching on Pregnancy Outcome
Adolescent pregnancy can present health challenges for both mothers and their babies. Pregnant adolescents who are experiencing their first pregnancy may need additional support to develop healthy practices, manage…
- Trial name
- Coaching (NCT07865273)
- Testing
- Digital Health Coaching Self-Management Program
- Where
- Jordan
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Al-Zaytoonah University of Jordan
Gynecologic Cancer
Follow-up in Gynecological Cancer Survivors
A cross-sectional prospective study of follow-up in gynecologic cancer patients after primary treatment
- Trial name
- NCT03515993
- Where
- 21 sites in Austria, Belgium and 7 more
- Volunteers
- 1,100 people
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
Benign Paroxismal Positional Vertigo
BPPV Recurrence After CRM With & Without Supplementation
Benign paroxysmal positional vertigo (BPPV) may frequently recur even after successful canalith repositioning maneuvers (CRMs). This study investigates whether the addition of vitamin K₂ to vitamin D₃ offers additional benefits…
- Trial name
- RR-BPPV-DK (NCT07861464)
- Testing
- Combined vitamin D₃ and K₂ supplementation, Vitamin D₃ alone, Canalith repositioning maneuver (CRM) alone
- Where
- Jordan
- Volunteers
- 404 people
- Sponsor
- University of Jordan
Mental Health, Reproductive Health
Integrated Digital Psychosocial and Reproductive Health E-Clinic for Women and Adolescent Girls in Jordan
This implementation study evaluates an integrated digital e-clinic designed to provide mental health, psychosocial, and reproductive health support to women and adolescent girls in Jordan, including Jordanian and Syrian refugee…
- Trial name
- AMAL-CLINIC (NCT07861945)
- Testing
- Integrated Digital MHPSS-Reproductive Health E-Clinic
- Where
- Jordan
- Volunteers
- 250 people
- Sponsor
- Jordan University of Science and Technology
Locally Advanced or Metastatic Breast Cancer
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human…
- Trial name
- NCT05296798
- Testing
- Phesgo, Giredestrant, Docetaxel
- Where
- 198 sites in United States, Argentina and 27 more
- Volunteers
- 922 people
- Sponsor
- Hoffmann-La Roche
Multiple Sclerosis
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)
- Trial name
- ENSURE-1 (NCT05134441)
- Testing
- IMU-838 tablets
- Where
- 103 sites in United States, Albania and 15 more
- Volunteers
- 1,121 people
- Sponsor
- Immunic AG
Cardiopulmonary Resuscitation (CPR), Knowledge
Comparing Instructor-led Versus Blended Cardiopulmonary Resuscitation Training Among Nursing Students
Objectives of the Study The current study aimed to investigate how individual and team personality traits, academic motivation, and academic procrastination predict CPR training outcomes at individual and team levels, and to what…
- Conditions
- Cardiopulmonary Resuscitation (CPR), Knowledge, Skill Retention, Competence
- Trial name
- NCT07851311
- Testing
- Blended learning, Instructor-led training
- Where
- Jordan
- Volunteers
- 208 people, healthy volunteers welcome
- Sponsor
- Applied Science Private University
Mental Health and Psychological Well-Being
Effectiveness of a Nurse-facilitated Artificial Intelligence Chatbot on Psychological Well-being and Mental Health Stigma Among Patients With Psychiatric Disorders: A Quasi-experimental Study
This quasi-experimental study aims to evaluate the effectiveness of a nurse-facilitated artificial intelligence (AI) chatbot in improving psychological well-being and reducing mental health stigma among patients with psychiatric…
- Trial name
- AI Chatbot (NCT07848022)
- Testing
- Nurse-Facilitated Artificial Intelligence Chatbot
- Where
- Jordan
- Volunteers
- 72 people
- Sponsor
- Al-Zaytoonah University of Jordan
Patient Anxiety During Upper Gastrointestinal Endoscopy
Artificial Intelligence-Based Virtual Reality on Patient With Upper Gastrointestinal Endoscopy
This randomized controlled trial evaluates whether an artificial intelligence-based virtual reality (AI-VR) relaxation intervention can improve patient outcomes during upper gastrointestinal endoscopy.
- Trial name
- Virtual (NCT07848009)
- Testing
- Artificial Intelligence-Based Virtual Reality Relaxation
- Where
- Jordan
- Volunteers
- 500 people
- Sponsor
- Al-Zaytoonah University of Jordan
Colitis, Ulcerative
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in participants with moderately to severely active ulcerative colitis (UC).
- Trial name
- ASTRO (NCT05528510)
- Testing
- Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3
- Where
- 236 sites in United States, Argentina and 23 more
- Volunteers
- 418 people
- Sponsor
- Janssen Research & Development, LLC
Paroxysmal Nocturnal Hemoglobinuria
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
This study is researching an experimental treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on people with paroxysmal nocturnal hemoglobinuria (PNH).
- Trial name
- ACCESS-EXT (NCT05744921)
- Testing
- Pozelimab, Cemdisiran
- Where
- 48 sites in Brazil, Canada and 18 more
- Volunteers
- 202 people
- Sponsor
- Regeneron Pharmaceuticals
Crohn's Disease
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.
- Trial name
- GALAXI (NCT03466411)
- Testing
- Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3
- Where
- 579 sites in United States, Australia and 41 more
- Volunteers
- 1,409 people
- Sponsor
- Janssen Research & Development, LLC
Colitis, Ulcerative
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial…
- Trial name
- DUET-UC (NCT05242484)
- Testing
- Guselkumab, Golimumab, JNJ-78934804
- Where
- 403 sites in United States, Argentina and 35 more
- Volunteers
- 577 people
- Sponsor
- Janssen Research & Development, LLC
Ulcerative Colitis
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).
- Trial name
- QUASAR (NCT04033445)
- Testing
- Guselkumab
- Where
- 392 sites in United States, Argentina and 32 more
- Volunteers
- 1,064 people
- Sponsor
- Janssen Research & Development, LLC
Crohn's Disease
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
- Trial name
- DUET-CD (NCT05242471)
- Testing
- Guselkumab, Golimumab, JNJ-78934804
- Where
- 456 sites in United States, Australia and 34 more
- Volunteers
- 703 people
- Sponsor
- Janssen Research & Development, LLC
Fistulizing Crohns Disease, Perianal Crohns Disease
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.
- Trial name
- FUZION CD (NCT05347095)
- Testing
- Guselkumab
- Where
- 154 sites in United States, Australia and 21 more
- Volunteers
- 288 people
- Sponsor
- Janssen-Cilag Ltd.